Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02806921
Other study ID # 14620
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2016
Est. completion date February 15, 2018

Study information

Verified date June 2019
Source University of Waterloo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate changes in the level of inflammatory mediators in the tear film of scleral contact lens wearers in a keratoconic population.


Description:

Scleral contact lenses are rigid gas permeable lenses designed to rest on the sclera while vaulting over the cornea with a fluid reservoir. The use of scleral contact lenses has become the current standard of practice as a nonsurgical management of corneal ectasia and ocular surface diseases. Cases have been recently presented of scleral lens wearers exhibiting adverse corneal findings and conjunctival injection from lens wear. These findings are likely associated with the mechanical and hypoxic effects due to poor fitting characteristics at the limbal area. Tear film analysis detecting changes in the levels of proteinases and cytokines have helped researchers gain a better understanding of the pathophysiology of complications in soft contact lenses wearers, dry eye, and keratoconus. Ultimately, this study will provide insights in relating scleral lens fitting characteristics and corneal and limbal physiological responses.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date February 15, 2018
Est. primary completion date January 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Had been diagnosed with keratoconus in at least one eye.

- Is at least 18 years of age and has full legal capacity to volunteer.

- Has read and understood the information consent letter.

- Is willing and able to follow instructions and maintain the appointment schedule.

Exclusion Criteria:

- Is using any topical medications that will affect ocular health.

- Has any ocular pathology or severe insufficiency of lacrimal secretion (severe dry eyes) that would affect the wearing of contact lenses.

- Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.

- Has any clinically significant lid or conjunctival abnormalities and active neovascularization.

- Is aphakic.

- Has undergone any corneal surgery.

- Is participating in any other type of eye related clinical or research study.

- Has any known allergies or sensitivity to the diagnostic pharmaceuticals or products, such as fluorescein, used in this study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ZenLens
The ZenLens™ semi-scleral lenses are manufactured by Alden Optic Laboratories Inc., Lancaster, NY. They will be made in Boston XO material.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Waterloo Bausch & Lomb Incorporated

Outcome

Type Measure Description Time frame Safety issue
Primary Tear Protein To measure the level proteases and cytokines in each of the samples using Meso Scale Discovery system (MSD-ECL). 2 weeks of lens wear with daily schedule of 6-8 hours.
Secondary Comfort Participants will be asked to rate their ocular comfort, dryness, burning and vision with the contact lenses. 2 weeks of lens wear with daily schedule of 6-8 hours.
Secondary Bulbar and limbal hyperemia The eyes of the participants will be imaged using the Keratograph® 5. 2 weeks of lens wear with daily schedule of 6-8 hours.
Secondary Corneal thickness Their corneal thickness will be measured with the Visante OCT. 2 weeks of lens wear with daily schedule of 6-8 hours.
See also
  Status Clinical Trial Phase
Recruiting NCT04570020 - Scleral Lens Fitting Using Wide-Field OCT
Recruiting NCT02921009 - McNeel Eye Center Corneal Crosslinking Study N/A
Terminated NCT02762253 - Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus. Phase 2
Completed NCT01691651 - Botulinum Toxin A for the Treatment of Keratoconus N/A
Completed NCT01527708 - Accuracy of Curvature and Wavefront Aberrations of Posterior Corneal Surface, in Keratoconic and Post-CXL Corneas N/A
Completed NCT01527721 - Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CxL Combined With Photorefractive Keratectomy (PRK) in Keratoconus N/A
Recruiting NCT00841386 - Treatment of Keratoconus Using Collagen Cross-Linking Phase 2/Phase 3
Completed NCT00347074 - A Clinical Study of Keratoconus in Asian Patients and Assessment of Different Topographic Patterns of Keratoconus in Asian Patients N/A
Completed NCT03187912 - Accelerated Corneal Cross-linking With Different Riboflavin Solutions Phase 3
Completed NCT00584285 - Corneal Topographer Fluorescein Patterns
Completed NCT03511495 - Reliability of Topography Measurements in Keratoconus
Not yet recruiting NCT05395650 - Cyanocobalamin as Photosensitizing Agent
Completed NCT04418999 - Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus Early Phase 1
Completed NCT03235856 - Retrospective Digital Computer Analysis of Keratoconus Evolution - REDCAKE
Completed NCT05019768 - Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS N/A
Withdrawn NCT01789333 - Higher Irradiance in Keratoconus Ectasia N/A
Completed NCT05114928 - Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.
Completed NCT03647046 - Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus N/A
Recruiting NCT04439552 - fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
Recruiting NCT06100939 - Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus Phase 3